Abstract
Purpose
End-stage renal disease (ESRD) and acquired renal cystic disease associated with dialysis are known risk factors of papillary renal cell carcinoma (pRCC); however, it is not known whether renal insufficiency alone is a risk factor for pRCC. Our aim was to test whether renal insufficiency is associated with an increased preponderance of pRCC.
Methods
Retrospective review of institutional database to identify all patients who underwent extirpative renal surgery for renal cell carcinoma (RCC) with complete records from 1992 to 2012. We excluded those patients with preoperative ESRD as defined by GFR < 15 mL/min/1.73 m2. The dependent variable was histologic RCC subtype. Independent variables included demographic data, comorbidities, and renal functional data. Multivariate analysis by binary logistic regression was used to determine factors that independently were associated with pRCC development.
Results
A total of 1,226 patients met inclusion criteria, of which 15 % were pRCC. There was a positive association between likelihood of pRCC histology of RCC and increasing preoperative chronic kidney disease (CKD) stage (p = 0.021). Multivariate regression analysis indicated that male gender, race, and declining renal function categorized both by GFR and CKD stage were independently associated with a higher likelihood of pRCC histology as compared to other RCC histology.
Conclusions
Within a large cohort of patients with a diagnosis of RCC, declining renal function was independently associated with an increased likelihood of pRCC histology. This finding and the available molecular evidence indicating protein expression similarity between pRCC and resident stem cells, which appear to be upregulated with kidney damage, suggest a possible causal relationship between renal injury and pRCC.
Similar content being viewed by others
References
Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63:11–30
Jayson M, Sanders H (1998) Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51:203–205
Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373:1119–1132
Schmidt L, Junker K, Nakaigawa N et al (1999) Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18:2343–2350
Schmidt LS, Nickerson ML, Angeloni D et al (2004) Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol 172:1256–1261
Stewart JH, Buccianti G, Agodoa L et al (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14:197–207
Bussolati B, Bruno S, Grange C et al (2005) Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166:545–555
Schwartz JDDFH JM, Wilson GD, Wolforth SC, Rooney MT, Wei L, Zhang PL (2013) CD133 Staining detects acute kidney injury and differentiates clear cell papillary renal cell carcinoma from other renal tumors. ISRN Biomark 2013, 8
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147
Campbell SCLBR (2012) Malignant renal tumors. In: Wein AJ (ed) Campbell-Walsh urology, vol 3, 10th edn. Elsevier, Philadelphia PA, p 4320
Ximing J, Yang KD, Jia L, Gersbach E, Lin F, Shen S, Teh BT (2013) Is papillary renal cell carcinoma derived from proximal convoluted tubules?. United States and Canadian Academy of Pathology Annual Meeting, Baltimore, MA
Renehan AG, Tyson M, Egger M et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578
Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. J Am Med Assoc 290:199–206
Fryzek JP, Poulsen AH, Johnsen SP et al (2005) A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92:1302–1306
Lipworth L, Tarone RE, McLaughlin JK (2006) The epidemiology of renal cell carcinoma. J Urol 176:2353–2358
Ljungberg B, Campbell SC, Choi HY et al (2011) The epidemiology of renal cell carcinoma. Eur Urol 60:615–621
McCredie M, Pommer W, McLaughlin JK et al (1995) International renal-cell cancer study. II. Analgesics. Int J Cancer 60:345–349
Park JH, Kim YO, Park JH et al (2000) Comparison of acquired cystic kidney disease between hemodialysis and continuous ambulatory peritoneal dialysis. Korean J Intern Med 15:51–55
Liu JS, Ishikawa I, Horiguchi T (2000) Incidence of acquired renal cysts in biopsy specimens. Nephron 84:142–147
Kasiske BL, Snyder JJ, Gilbertson DT et al (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4:905–913
Klatte T, Marberger M (2011) Renal cell carcinoma of native kidneys in renal transplant patients. Curr Opin Urol 21:376–379
Hofmann JN, Schwartz K, Chow WH et al (2013) The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans. Cancer Causes Control 24:167–174
Weng PH, Hung KY, Huang HL et al (2011) Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin J Am Soc Nephrol 6:1121–1128
Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14:2199–2210
Angelotti ML, Ronconi E, Ballerini L et al (2012) Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30:1714–1725
Kim K, Park BH, Ihm H et al (2011) Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis. Histol Histopathol 26:223–232
Lindgren D, Bostrom AK, Nilsson K et al (2011) Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol 178:828–837
Reuter VE (2006) The pathology of renal epithelial neoplasms. Semin Oncol 33:534–543
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
This retrospective human study has been approved by the Columbia University Medical Center institutional review board and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients have given their informed consent to be part of our institutional surgical registry of genitourinary cancers.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Woldu, S.L., Weinberg, A.C., RoyChoudhury, A. et al. Renal insufficiency is associated with an increased risk of papillary renal cell carcinoma histology. Int Urol Nephrol 46, 2127–2132 (2014). https://doi.org/10.1007/s11255-014-0780-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0780-4